1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.09%
Negative revenue growth while 6247.T stands at 14.28%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
20.02%
Gross profit growth above 1.5x 6247.T's 9.32%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
220.05%
EBIT growth 1.25-1.5x 6247.T's 160.00%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
433.12%
Operating income growth above 1.5x 6247.T's 36.73%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
584.80%
Net income growth above 1.5x 6247.T's 172.12%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
586.19%
EPS growth above 1.5x 6247.T's 172.05%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
586.19%
Diluted EPS growth above 1.5x 6247.T's 172.05%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 6247.T is at 0.04%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6247.T is at 0.04%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
2.62%
OCF growth above 1.5x 6247.T's 0.38%. David Dodd would confirm a clear edge in underlying cash generation.
2.62%
FCF growth above 1.5x 6247.T's 0.38%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.20%
10Y revenue/share CAGR at 75-90% of 6247.T's 85.95%. Bill Ackman would press for new markets or product lines to narrow the gap.
10.27%
5Y revenue/share CAGR under 50% of 6247.T's 69.78%. Michael Burry would suspect a significant competitive gap or product weakness.
2.58%
3Y revenue/share CAGR under 50% of 6247.T's 16.95%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.33%
Below 50% of 6247.T's 223.35%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
614.27%
5Y net income/share CAGR 1.25-1.5x 6247.T's 415.96%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-27.77%
Negative 3Y CAGR while 6247.T is 95.40%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
355.71%
10Y equity/share CAGR above 1.5x 6247.T's 49.29%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.84%
5Y equity/share CAGR above 1.5x 6247.T's 13.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.87%
3Y equity/share CAGR above 1.5x 6247.T's 6.17%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.00%
Firm’s AR is declining while 6247.T shows 9.03%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
10.48%
Inventory growth well above 6247.T's 0.22%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.49%
Negative asset growth while 6247.T invests at 1.42%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.76%
BV/share growth above 1.5x 6247.T's 0.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-8.16%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.59%
We increase R&D while 6247.T cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.72%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.